HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

LY 402913

an MRP1 modulator; structure in first source

Also Known As:

LY-402913; LY402913

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Isoxazoles: 155
      - LY 402913: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Quinolines: 146
      - Quinolones: 2938
        LY 402913: 1

Experts

1.	Dantzig, Anne H: 1 article (03/2002)
2.	Gruber, Joseph M: 1 article (03/2002)
3.	Hollinshead, Sean P: 1 article (03/2002)
4.	Law, Kevin L: 1 article (03/2002)
5.	Norman, Bryan H: 1 article (03/2002)
6.	Paul, Donald C: 1 article (03/2002)
7.	Self, Tracy D: 1 article (03/2002)
8.	Starling, James J: 1 article (03/2002)
9.	Tabas, Linda B: 1 article (03/2002)
10.	Wagner, Margaret M: 1 article (03/2002)

Related Diseases

1.	Neoplasms (Cancer) 03/25/2002 - "Finally, when dosed in combination with the oncolytic MRP1 substrate vincristine, LY 402913 delays the growth of MRP1-overexpressing tumors in vivo."

Related Drugs and Biologics

1.	Vincristine (Oncovin)
2.	multidrug resistance-associated protein 1